Stay updated on ALT-801 in Overweight and Obese T2DM: Clinical Trial
Sign up to get notified when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.

Latest updates to the ALT-801 in Overweight and Obese T2DM: Clinical Trial page
- Check7 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference2%
- Check14 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check21 days agoChange DetectedThe page has updated the dosing information for ALT-801, including new dosage levels and a change in the BMI classification for obesity. Additionally, the study director's name has been added.SummaryDifference7%
- Check29 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
Stay in the know with updates to ALT-801 in Overweight and Obese T2DM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.